Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueTax ProvisionsTax Rate
Others
Ratios

Acadia Healthcare Company (ACHC) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Acadia Healthcare Company (ACHC) over the last 16 years, with Q2 2025 value amounting to $8.7 million.

  • Acadia Healthcare Company's Other Operating Expenses fell 9870.24% to $8.7 million in Q2 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year decrease of 4708.95%. This contributed to the annual value of $2.6 billion for FY2024, which is 2624523.44% up from last year.
  • As of Q2 2025, Acadia Healthcare Company's Other Operating Expenses stood at $8.7 million, which was down 9870.24% from $714.3 million recorded in Q1 2025.
  • In the past 5 years, Acadia Healthcare Company's Other Operating Expenses registered a high of $714.3 million during Q1 2025, and its lowest value of $8.7 million during Q2 2025.
  • Moreover, its 5-year median value for Other Operating Expenses was $585.4 million (2022), whereas its average is $561.0 million.
  • As far as peak fluctuations go, Acadia Healthcare Company's Other Operating Expenses surged by 1777.96% in 2022, and later tumbled by 9870.24% in 2025.
  • Over the past 5 years, Acadia Healthcare Company's Other Operating Expenses (Quarter) stood at $484.1 million in 2021, then rose by 17.78% to $570.1 million in 2022, then rose by 14.21% to $651.2 million in 2023, then rose by 6.72% to $694.9 million in 2024, then plummeted by 98.75% to $8.7 million in 2025.
  • Its last three reported values are $8.7 million in Q2 2025, $714.3 million for Q1 2025, and $694.9 million during Q4 2024.